Frank David 5/8/13 Frank David 5/8/13

Taking on the "pharmascolds"

It's time to stop demonizing research interactions between physicians and Pharma, and start fighting rhetorical fire with hard data.

Frank David 4/25/13 Frank David 4/25/13

Performance-based pricing, part 2

A few more thoughts on drug pricing, following up on a prior post.

Frank David 4/21/13 Frank David 4/21/13

We have tools available today to improve the drug pricing system. Let's start using them.

Frank David 4/9/13 Frank David 4/9/13

If Pharma companies want to succeed in cancer R&D, they need to get better at handling combinations. Here are some places to start.